Patents by Inventor Sauro BONELLI

Sauro BONELLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AEROSOL FORMULATION FOR COPD
    Publication number: 20150306026
    Abstract: Stable aerosol solution formulations comprising glycopyrronium bromide are useful for administration to patients with COPD and other respiratory conditions.
    Type: Application
    Filed: July 6, 2015
    Publication date: October 29, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Francesca USBERTI, Enrico ZAMBELLI
  • STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
    Publication number: 20150182450
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Application
    Filed: December 30, 2014
    Publication date: July 2, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Diego COPELLI, Massimiliano Dagli ALBERI, Francesca USBERTI, Enrico ZAMBELLI
  • STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
    Publication number: 20150182459
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Application
    Filed: December 30, 2014
    Publication date: July 2, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Diego COPELLI, Massimiliano Dagli ALBERI, Francesca USBERTI, Enrico ZAMBELLI
  • COMBINATION THERAPY FOR COPD
    Publication number: 20140363384
    Abstract: Aerosol formulations comprising glycopyrronium chloride in combination with formoterol may be administered by means of a pressurized metered dose inhaler (pMDI) for the prevention or treatment of chronic obstructive pulmonary disease. The formulation further comprises a HFA propellant, a co-solvent, and an amount of inorganic acid sufficient to stabilize both the glycopyrronium chloride and the formoterol components. Optionally, the formulation may further comprise beclometasone dipropionate.
    Type: Application
    Filed: August 25, 2014
    Publication date: December 11, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A
    Inventors: Sauro BONELLI, Francesca USBERTI, Enrico ZAMBELLI
  • AEROSOL FORMULATION FOR COPD
    Publication number: 20140363383
    Abstract: The stable aerosol solution formulations comprising glycopyrronium chloride are useful for administration to patients with COPD and other respiratory conditions.
    Type: Application
    Filed: August 25, 2014
    Publication date: December 11, 2014
    Applicant: Chiesi Farmaceutici S.p.A
    Inventors: Sauro BONELLI, Francesca Usberti, Enrico Zambelli
  • PHARMACEUTICAL FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
    Publication number: 20120034172
    Abstract: Pharmaceutical formulations to be administered by pressurized metered dose inhalers (pMDIs), comprising a compound of general formula (I) may be used for the treatment and/or prevention of inflammatory or obstructive airway diseases.
    Type: Application
    Filed: August 2, 2011
    Publication date: February 9, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Elena Losi, Enrico Zambelli
  • AEROSOL FORMULATION FOR COPD
    Publication number: 20110146677
    Abstract: The stable aerosol solution formulations comprising glycopyrronium chloride are useful for administration to patients with COPD and other respiratory conditions.
    Type: Application
    Filed: December 23, 2010
    Publication date: June 23, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Sauro BONELLI, Francesca Usberti, Enrico Zambelli
  • AEROSOL FORMULATION FOR COPD
    Publication number: 20110150783
    Abstract: Stable aerosol solution formulations comprising glycopyrronium bromide are useful for administration to patients with COPD and other respiratory conditions.
    Type: Application
    Filed: December 23, 2010
    Publication date: June 23, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Sauro BONELLI, Francesca Usberti, Enrico Zambelli
  • COMBINATION THERAPY FOR COPD
    Publication number: 20110150782
    Abstract: Aerosol formulations comprising glycopyrronium bromide in combination with formoterol are useful for the prevention or treatment of chronic obstructive pulmonary disease. The formulation further comprises a HFA propellant, a co-solvent, and an amount of inorganic acid sufficient to stabilize both the glycopyrronium bromide and the formoterol components. Optionally the formulation may further comprise beclometasone dipropionate.
    Type: Application
    Filed: December 23, 2010
    Publication date: June 23, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Sauro BONELLI, Francesca Usberti, Enrico Zambelli
  • COMBINATION THERAPY FOR COPD
    Publication number: 20110150784
    Abstract: Aerosol formulations comprising glycopyrronium chloride in combination with formoterol may be administered by means of a pressurized metered dose inhaler (pMDI) for the prevention or treatment of chronic obstructive pulmonary disease. The formulation further comprises a HFA propellant, a co-solvent, and an amount of inorganic acid sufficient to stabilize both the glycopyrronium chloride and the formoterol components. Optionally, the formulation may further comprise beclometasone dipropionate.
    Type: Application
    Filed: December 23, 2010
    Publication date: June 23, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Sauro Bonelli, Francesca Usberti, Enrico Zambelli
  • PHARMACEUTICAL FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG
    Publication number: 20090180969
    Abstract: Pharmaceutical formulations suitable to be administered by pressurised metered dose inhalers (pMDIs) comprising a salt of 3-[[[(3-fluorophenyl)[(3,4,5-trifluoro phenyl)methyl]amino]carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane are effective for the prevention and/or treatment of an obstructive airways disease.
    Type: Application
    Filed: December 24, 2008
    Publication date: July 16, 2009
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Sauro BONELLI, Massimiliano Dagli Alberi